Bevacizumab and nausea 
Bevacizumab and nausea Patient Reports February 10, 2010
Bevacizumab Side Effects Report #5765289-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypertension, hypothyroidism, nausea . Bevacizumab dosage: 15 MG/KG (690 MG) Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5782995-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , refusal of treatment by patient, treatment noncompliance. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5852586-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , refusal of treatment by patient. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6021215-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2008. Female patient, weighting 106.7 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, blood glucose increased, dizziness , nausea , pancreatic insufficiency. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5750324-0
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 21, 2008. Male patient, 69 years of age, weighting 135.8 lb, was diagnosed with rectal cancer, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastric antral vascular ectasia, gastric haemorrhage, gastroduodenal ulcer, haematemesis, nausea , unevaluable event. Bevacizumab dosage: 345 MG ONCE IV. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4925960-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 24, 2006. Male patient, 64 years of age, weighting 242.5 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, cardiac arrest , chest pain , dysarthria, nausea , speech disorder, tremor, ventricular fibrillation. Bevacizumab dosage: 5MG/KG = 550 MG. During the same period patient was treated with OXALIPLATIN IV, LEUKOVORIN IV, FLUOROURACIL, TYLENOL, ZOFRAN, DECADRON SRC, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4941370-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2006. Male patient, 64 years of age, weighting 242.5 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, cardiac arrest , chest pain , dysarthria, ejection fraction decreased, electrocardiogram qt corrected interval prolonged, nausea , tremor, ventricular dysfunction. Bevacizumab dosage: 5 MG/KG =550 MG. During the same period patient was treated with OXALIPLATIN IV, LEUKOVORIN IV, TYLENOL, ZOFRAN, DECADRON SRC, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5487239-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Female patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, nausea
. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5224744-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2007. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chills, dehydration, fatigue, mucosal inflammation, myalgia, nausea , pyrexia, unevaluable event. Bevacizumab dosage: 455 MG X1 IV. During the same period patient was treated with DOCETAXEL, CHEMO, LISINOPRIL, POTASSIUM ACETATE, FERROS GLUCONATE, FUROSEMIDE, GLYBURIDE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5301949-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 16, 2007. Male patient, weighting 220.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dizziness , dyspnoea exertional, dysstasia, faeces discoloured, nausea , presyncope, pyrexia. Bevacizumab dosage: 1500 MG Q THREE WEEKS IV DRIP. During the same period patient was treated with ERLOTINIB, AVASTIN, TAXOTERE, PREDNISONE, TARCEVA, ACTOPLUS, ASPIRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6109467-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2009. Male patient, 67 years of age, weighting 190.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, deep vein thrombosis
, gastric disorder, gastrointestinal disorder, hepatic lesion, hiccups, intestinal fistula, nausea , neoplasm progression. Bevacizumab dosage: 10MG/KG IV, D1+15 28DAY. During the same period patient was treated with GEMCITABINE, FLUOROURACIL, AMBIEN, ATENOL, ATIVAN, AVANDARYL, DARVOCET, LANTUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6109485-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2009. Male patient, 67 years of age, weighting 190.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, deep vein thrombosis
, gastric disorder, gastrointestinal disorder, hepatic lesion, hiccups, intestinal fistula, nausea , neoplasm progression. Bevacizumab dosage: 10MG/KGIV, D1+15 28 DAY. During the same period patient was treated with GEMCITABINE, FLUOROURACIL, AMBIAN PRN, ATENOL, ATIVAN PRN, AVANDARYL, DARVOCET, LANTUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6092356-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2009. Male patient, weighting 201.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, disease progression, nausea . Bevacizumab dosage: 15MG/KG, 1370 MG EVERY 3 WEEKS IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5782559-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 09, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea
. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5911508-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea
. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5985129-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, hypertension, nausea
. Bevacizumab dosage: 387 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ASPIRIN, ATORVASTATIN CALCIUM, BENDROFLUAZIDE, CALCICHEW, CITALOPRAM HYDROBROMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6045605-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fall
, foot fracture, nausea , syncope. Bevacizumab dosage: 465 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TILIDINE, NOVALGIN, AMLODIPINE, CYMBALTA, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4905345-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 20, 2006. Female patient, 39 years of age, weighting 226.9 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, abdominal pain lower, anal fistula, body temperature increased, decreased appetite, diarrhoea, heart rate increased, nausea . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, ASPIRIN, ATIVAN, LIPITOR, LOPRESSOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5728613-5
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 02, 2008. Male patient, 34 years of age, weighting 208.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, eructation, gastrointestinal necrosis, nausea
, oesophageal ulcer, retching. Bevacizumab dosage: 1035MG (15MG/KG) EVERY 21 TO 28 DAYS IV. Patient recovered.Bevacizumab Side Effects Report #5279562-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 13, 2007. Male patient, 69 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal tenderness, erosive oesophagitis, nausea
, weight decreased. Bevacizumab dosage: 1395 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, DEXAMETHASONE, REGLAN, PACLITAXEL, EMEND, KYTRIL, PHENERGAN, PRILOSEC. Patient was hospitalized and became disabled. Patient recovered.Bevacizumab Side Effects Report #5821247-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 22, 2008. Male patient, 67 years of age, weighting 187.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, decreased appetite, metastases to pancreas, nausea , weight decreased. Bevacizumab dosage: 15 MG/KG ONCE EVERY 3 WEEKS IV DRIP. During the same period patient was treated with BORTEZOMIB MILLENNIUM, LISINOPRIL, ACTOS, METOPROLOL SUCCINATE, GLIMEPIRIDE, ISOSORBIDE DINITRATE, GLIPIZIDE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5147188-5
Bevacizumab side effect was reported by a Health Professional from CANADA on Oct 18, 2006. Male patient, 65 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, colitis, cough, hypokalaemia, ileus, leukocytosis, nausea
, pneumothorax, sputum discoloured. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, DOCUSATE, PROCHLORPERAZINE, SENOKOT, ZANTAC, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5060022-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 11, 2006. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, nausea
. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5041299-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 16, 2006. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, nausea
. Bevacizumab dosage: 10 MG/KG,. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5296017-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, weighting 133.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, constipation
, nausea . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5301509-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.Bevacizumab Side Effects Report #5312790-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.Bevacizumab Side Effects Report #5351069-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 01, 2007. Female patient, weighting 133.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, constipation
, nausea . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5651514-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, epistaxis, nausea
. Bevacizumab dosage: 1050 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CHLORPHENAMINE, CYCLIZINE, CODEINE SUL, ACETAMINOPHEN. Patient died.Bevacizumab Side Effects Report #5655931-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: clostridial infection, diarrhoea, epistaxis, nausea
. Bevacizumab dosage: 1050 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CHLORPHENAMINE, CYCLIZINE, CODEINE SUL, ACETAMINOPHEN. Patient was hospitalized. Patient died.Bevacizumab Side Effects Report #6038013-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, weighting 193.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, dehydration, nausea , obstruction. Bevacizumab dosage: 10 MG/KG - IV Q2WEEKS 1 TREATMENT. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMBIVANT, LIPITOR, ZEMBETA, ZYRTEC, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6053888-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 216.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, diarrhoea, dysuria, hypophagia, nausea
, neutropenia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4796678-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Oct 06, 2005. Male patient, 48 years of age, weighting 216.5 lb, was diagnosed with neuroendocrine tumour and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, nausea
. Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6045940-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 13, 2009. Male patient, 82 years of age, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: infection
, mucosal inflammation, nausea , urinary retention. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5127395-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2006. Male patient, 56 years of age, weighting 176.4 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: feeding tube complication, nausea
. Bevacizumab dosage: 812 MG WEEKS 1,3. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DULCOLAX, DECADRON, PRILOSEC, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5143840-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Male patient, 56 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, dehydration, hiccups, nausea
, pneumonia . Bevacizumab dosage: 812MG WKS 1,3,5 DELAYED. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DULCOLAX, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5151045-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Male patient, 56 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea
. Bevacizumab dosage: 812MG WKS 1,3,5 DELAYED. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DUCLOLAX, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5725795-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 09, 2008. Female patient, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, feeding tube complication, infection
, nausea , oesophagitis, stomatitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5215812-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 02, 2007. Male patient, 38 years of age, was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, flatulence, gastrointestinal disorder, metastases to liver, metastases to lymph nodes, metastases to spleen, nausea . Bevacizumab dosage: 10 MG/KG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5977621-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2008. Male patient, 71 years of age, weighting 172.4 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood pressure orthostatic, dehydration, fluid intake reduced, hypophagia, nausea
, neutropenia. Bevacizumab dosage: 7.5 MG/KG D1/22DAYCYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, DECADRON, OMEPRAZOLE, RESTORIL, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5156251-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea
, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5179363-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea
, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5967955-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2008. Female patient, 47 years of age, weighting 107.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, catheter site related reaction, cellulitis , gastrointestinal stoma complication, nausea , neutropenia, secretion discharge. Bevacizumab dosage: 7.5 MG/KG D1/22DAYCYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, COLACE, LUNESTA, OMEPRAZOLE, TRAMADOL, VITAMIN B, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5324283-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 04, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5328627-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5498601-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, muscle spasms, nausea
, small intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6106448-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2009. Male patient, weighting 117.1 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, disease progression, loss of consciousness, nausea , weight decreased. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, MS CONTIN, OXALIPLATIN, TYLENOL W. Patient was hospitalized. Patient died on 02/21/2009.Bevacizumab Side Effects Report #5389966-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on July 16, 2007. Female patient, 46 years of age, weighting 166.0 lb, was diagnosed with lung cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dizziness
, headache , nausea , oral intake reduced, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 1200MG, 1175MG, 1125MG. Patient recovered.Bevacizumab Side Effects Report #4724439-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 22, 2005. Female patient, 51 years of age, weighting 197.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis, nausea
. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, ALBUTEROL, CELEXA, COMPAZINE, GLYBURIDE, IBUPROFEN, LANCETS, LANTUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5736177-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 09, 2008. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with head and neck cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disorientation, hypertension, leukoencephalopathy, nausea , tonic clonic movements, visual disturbance. Bevacizumab dosage: 614 MG, Q 2 WKS, IV. During the same period patient was treated with CISPLATIN, TARCEVA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5668725-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2008. Female patient, 67 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, chest pain
, dehydration, nausea . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5290488-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, fall
, hyponatraemia, nausea . Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5297826-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, disease progression, fall
, hyponatraemia, nausea , pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5301842-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, fall
, hyponatraemia, malignant neoplasm progression, nausea , nuclear magnetic resonance imaging brain abnormal, pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient died on 04/13/2007.Bevacizumab Side Effects Report #5173441-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2006. Female patient, weighting 152.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: grand mal convulsion, hypertension, hyponatraemia, nausea
, postictal paralysis. Bevacizumab dosage: 698MG QOW IV. During the same period patient was treated with IRINOTECAN, CARBATROL, PHENOBARBITAL, BONE CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5879321-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2008. Male patient, weighting 332.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, glioblastoma multiforme, ileus, malignant neoplasm progression, nausea , pyrexia, small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with BORTIZOMIB, PROVIGIL, TRAZODONE, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5814025-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 09, 2008. Male patient, weighting 196.2 lb, was diagnosed with glioblastoma, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea , pyrexia, spinal fracture. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with BORTEZOMIB, OMNICEF, MS CONTIN, VICODIN, DILANTIN, DECADRON, ZESTRIL, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5872059-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 21, 2008. Female patient was diagnosed with gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, nausea
. Bevacizumab dosage: 400 MG, UNK. During the same period patient was treated with CAPECITABINE, EPIRUBICIN, CISPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4799681-2
Bevacizumab side effect was reported by a Health Professional from ITALY on Sept 21, 2005. Female patient, 63 years of age, weighting 101.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium decreased, diarrhoea, nausea
, pyrexia. Bevacizumab dosage: 345 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, IRINOTECAN, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5333448-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 09, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, intestinal obstruction, nausea
. Bevacizumab dosage: 7.5 MG/M2, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5395582-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 09, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, intestinal obstruction, nausea
. Bevacizumab dosage: 7.5 MG/M2, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5431730-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 16, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood creatinine increased, blood urea increased, diarrhoea, musculoskeletal chest pain, nausea
, weight decreased. Bevacizumab dosage: 570 MG, Q3W. During the same period patient was treated with CAPECITABINE, IRINOTECAN, KETOPROFEN, LYTOS, TRAMADOL. Patient died on 08/09/2007.Bevacizumab Side Effects Report #5450440-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 30, 2007. Female patient, weighting 138.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, lethargy, nausea
, renal failure acute, urinary tract infection . Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, FLUCLOXACILLIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5529488-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 14, 2007. Male patient, weighting 192.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, nausea
, pain , pyrexia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, COMPAZINE, HYDROCODONE BITARTRATE, ROBAXIN, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5535651-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 23, 2007. Female patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastritis, nausea
. Bevacizumab dosage: 510 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN C. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5573799-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 13, 2007. Male patient, weighting 192.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fatigue, nausea
, pain , pyrexia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, COMPAZINE, HYDROCODONE BITARTRATE, ROBAXIN, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5641710-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, nausea
. Bevacizumab dosage: 7.5 MG/M2, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5810724-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 16, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, nausea
. Bevacizumab dosage: 255 MG, Q2W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, CODEINE SUL, ACETAMINOPHEN, TYLENOL. Patient was hospitalized. Patient died on 06/07/2008.Bevacizumab Side Effects Report #5845809-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 31, 2008. Female patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastritis, nausea
. Bevacizumab dosage: 4000 MG, D1-14/Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, LOPERAMIDE, MICARDIS, TEMAZEPAM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5957424-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2008. Female patient, weighting 132.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, creatinine renal clearance decreased, dehydration, diarrhoea, fatigue, nausea
, platelet count increased. Bevacizumab dosage: 450 MG, Q3W. During the same period patient was treated with CAPECITABINE, ASPIRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4670232-6
Bevacizumab side effect was reported by a Physician from on May 02, 2005. Male patient, 81 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, aspiration, atrial fibrillation , disease progression, hypotension, loss of consciousness, myocardial ischaemia, nausea , neutropenia. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, CALCIUM LEUCOVORIN, FLUOROURACIL. Patient was hospitalized. Patient died on 02/06/2003.Bevacizumab Side Effects Report #5174214-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 22, 2006. Male patient, 61 years of age, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, diarrhoea, hypokalaemia, hypomagnesaemia, hyponatraemia, hypophosphataemia, intestinal obstruction, nausea . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5721937-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea , renal failure. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6028916-3
Bevacizumab side effect was reported by a Physician from GREECE on Dec 23, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: biliary cirrhosis primary, cardiac failure, cardiotoxicity, diarrhoea, disease progression, hepatic failure, mucosal inflammation, nausea , pancytopenia. Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with CAPECITABINE, IRINOTECAN, DEXAMETHASONE, ATROPINE, TACROLIMUS. Patient died.Bevacizumab Side Effects Report #5827260-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 15, 2008. Male patient, weighting 143.3 lb, was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea
, stomatitis. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, CANDESARTAN CILEXETIL, INDAPAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5315565-5
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Apr 30, 2007. Male patient, 85 years of age, weighting 193.6 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, diarrhoea, dyspnoea, hypotension, ileus, malaise, myocardial infarction, nausea
, pneumatosis. Bevacizumab dosage: 700 MG ONCE IV. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5420933-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2007. Female patient, 61 years of age, weighting 176.8 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure diastolic increased, blood pressure systolic inspiratory decreased, grand mal convulsion, headache
, loss of consciousness, nausea , retching, urinary incontinence . Bevacizumab dosage: 5MG/KG Q 2 WEEKS IV. Patient recovered.Bevacizumab Side Effects Report #5403211-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 17, 2007. Female patient, 53 years of age, weighting 140.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, dehydration, ileus, intestinal perforation, nausea
, oral intake reduced, sepsis , small intestinal obstruction. Bevacizumab dosage: 5MG/KG Q2W IV. During the same period patient was treated with COUMADIN, PROZAC, SYNTHROID, VICODIN, COMPAZINE. Patient was hospitalized. Patient died on 06/30/2007.Bevacizumab Side Effects Report #4917058-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Feb 16, 2006. Male patient, 50 years of age, weighting 178.6 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, nausea
. Bevacizumab dosage: 5MG/KG. During the same period patient was treated with OXALIPLATIN, CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5253930-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Female patient, weighting 98.00 lb, was diagnosed with colon cancer metastatic, metastases to liver and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hyponatraemia, nausea
. Bevacizumab dosage: 5MG/KG Q 2WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5814027-6
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on June 19, 2008. Female patient, weighting 88.18 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea
, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, CALCIUM LEVOFOLINATE, DECADRON, NOVAMIN, DOMPERIDON, ACARBOSE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5922238-4
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Oct 02, 2008. Female patient, weighting 88.18 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, nausea
, pyrexia. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, DECADRON, NOVAMIN, DOMPERIDON, ACARBOSE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5268674-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Female patient, weighting 94.00 lb, was diagnosed with colon cancer, metastases to liver and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: carbohydrate antigen 19-9 increased, dehydration, diarrhoea, hyponatraemia, nausea
, pancreatitis. Bevacizumab dosage: 5MG/KG Q 2 WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5471948-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 14, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea
, oral intake reduced. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, FAMOTIDINE, FERROUS SULPHATE, ALUMINUM HYDROXIDE GEL, ALGINIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5710466-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 11, 2008. Female patient, weighting 129.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood calcium decreased, blood potassium decreased, cardiac failure congestive, hypovolaemia, mental status changes, myocardial infarction, nausea
, respiratory failure. Bevacizumab dosage: 300 MG, Q2W. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM, CIPROFLOXACIN, TENORMIN, CLONIDINE, HYZAAR. Patient was hospitalized. Patient died on 03/29/2008.Bevacizumab Side Effects Report #5720506-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, gastrointestinal obstruction, hypokalaemia, hyponatraemia, hypophosphataemia, infection
, nausea , neutrophil count decreased. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, ELOXATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5739576-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 02, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastrointestinal obstruction, hypokalaemia, hypophosphataemia, infection
, nausea . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with XELODA, ELOXATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5844421-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 29, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal infection, anaemia, febrile neutropenia, metrorrhagia, nausea
, platelet count decreased, pyrexia, rash . Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, KYTRIL, DEXAMETHASONE PHOSPHATE, DECADRON SRC. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4712867-8
Bevacizumab side effect was reported by a Physician from AUSTRALIA on June 24, 2005. Female patient, 64 years of age, weighting 146.8 lb, was diagnosed with clear cell carcinoma of the kidney and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: back pain
, blood pressure increased, dizziness , headache , impaired healing, large intestine perforation, nausea , pelvic abscess, small intestinal obstruction. Bevacizumab dosage: 10 MG/KG,Q2W, INTRAVENOUS. During the same period patient was treated with INTERFERON ALFA, DEXAMETHASONE, COVERSYL, XALATA, CARDIZEM, METOCLOPRAMIDE, MORPHINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4978369-9
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Mar 28, 2006. Female patient, 64 years of age, weighting 136.7 lb, was diagnosed with clear cell carcinoma of the kidney and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: back pain
, blood pressure increased, constipation , dizziness , headache , impaired healing, large intestine perforation, nausea , pelvic abscess. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with INTERFERON ALFA, DEXAMETHASONE, COVERSYL, XALATAN, CARDIAZEM, METOCLOPRAMIDE, MORPHINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5310546-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 17, 2007. Female patient, weighting 127.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal rigidity, anxiety
, diarrhoea, epistaxis, nausea . Bevacizumab dosage: 580 MG, QOW. During the same period patient was treated with TAXOL, SPIRONOLACTONE, KETOPROFEN, DURAGESIC, ACETAMINOPHEN, TEMESTA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5834105-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 21, 2008. Female patient, weighting 151.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal ulcer, nausea
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, CELECOXIB, HYDROMORPHONE, SYNTHROID, CALCIUM, VITAMIN D, ATIVAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5807708-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2008. Female patient, 51 years of age, weighting 69.59 lb, was diagnosed with breast cancer
, nausea , constipation and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: eye pain, migraine , nausea . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ACYCLOVIR, ADVAIR DISKUS, ATIVAN, COLACE, COMPAZINE, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5821972-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 16, 2008. Female patient, 51 years of age, weighting 69.59 lb, was diagnosed with breast cancer
, nausea , constipation and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: eye pain, migraine , nausea . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ACYCLOVIR, ADVAIR DISKUS, ATIVAN, COLACE, COMPAZINE, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5884894-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 15, 2008. Female patient, 46 years of age, weighting 154.1 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure, dyspnoea, fatigue, malaise, nausea , productive cough. Bevacizumab dosage: 15MG/KG IV Q 3 WEEKS. During the same period patient was treated with CAPECITABINE, ATIVAN, EFFEXOR. Patient was hospitalized. Patient died on 09/04/2008.Bevacizumab Side Effects Report #5132911-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 19, 2006. Female patient, weighting 142.4 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain lower, lower gastrointestinal haemorrhage, nausea . Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS 042. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5853292-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: nausea , pyrexia. Bevacizumab dosage: 1350 MG, UNK. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6056961-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, nausea . Bevacizumab dosage: 1710 MG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, LIPITOR, OMEPRAZOLE, NEXIUM, FUROSEMIDE, NULYTELY. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6082637-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 03, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, nausea . Bevacizumab dosage: 1710 MG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, LIPITOR, OMEPRAZOLE, NEXIUM, FUROSEMIDE, NULYTELY. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5602838-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 14, 2008. Male patient, weighting 191.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, aspergillosis, diarrhoea, enteritis, injury, nausea . Bevacizumab dosage: 450 MG, UNK. During the same period patient was treated with DAUNOMYCIN, CYTARABINE, METOPROLOL TARTRATE, NEXIUM, CEFTAZIDIME, FLAGYL, MORPHINE, PREDNISOLONE. Patient died on 01/16/2008.Bevacizumab Side Effects Report #5635486-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 07, 2008. Male patient, weighting 191.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, aspergillosis, diarrhoea, enteritis, injury, nausea . Bevacizumab dosage: 450 MG, UNK. During the same period patient was treated with DAUNOMYCIN, CYTARABINE, METOPROLOL TARTRATE, NEXIUM, CEFTAZIDIME, FLAGYL, MORPHINE, PREDNISOLONE. Patient died on 01/16/2008.